|
|
Article: Drug-Eluting Stents Help Pave Way For Drug/Device Combos.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
MINNEAPOLIS- The convergence of the medical device and drug industries is inevitable, especially given the early success of drug-coated stents and inhaled insulin, but it could be years before the approval of combination products becomes everyday news, panelists said at the BIO Mid-America VentureForum.
Since the Midwest is known more for its established medtech and medical device industry, a workshop dealing with the reality of biotech drugs being packaged with devices seemed more than natural. But one panelist in a workshop at the Hilton Minneapolis Hotel warned not to put too much hope in the immediate future.
Peyton Anderson, ...